Observational (n=19,286)
Yes
Absolute Event Rate: 21.1% vs 35.4%
p-value: p=<.001
Hypothesis-generating for endovascular therapy in high-risk PE; randomized trials needed before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
DeRiso et al. (2026) conducted an observational in High-risk pulmonary embolism (HRPE) (n=19,286). Endovascular treatment (ENDO) vs. Systemic thrombolysis (ST) was evaluated on Mortality (p=<.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: